nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—CYP2J2—Cholecalciferol—ulcerative colitis	0.273	0.4	CbGbCtD
Apixaban—ABCB1—ulcerative colitis	0.231	1	CbGaD
Apixaban—ABCG2—Sulfasalazine—ulcerative colitis	0.0311	0.0455	CbGbCtD
Apixaban—ABCG2—Hydrocortisone—ulcerative colitis	0.0249	0.0365	CbGbCtD
Apixaban—CYP2C8—Nicotine—ulcerative colitis	0.0213	0.0311	CbGbCtD
Apixaban—CYP3A4—Budesonide—ulcerative colitis	0.0198	0.029	CbGbCtD
Apixaban—CYP2C8—Cholecalciferol—ulcerative colitis	0.0191	0.0279	CbGbCtD
Apixaban—CYP2C19—Nicotine—ulcerative colitis	0.0179	0.0261	CbGbCtD
Apixaban—CYP3A5—Sulfasalazine—ulcerative colitis	0.0172	0.0252	CbGbCtD
Apixaban—CYP1A2—Nicotine—ulcerative colitis	0.0165	0.0241	CbGbCtD
Apixaban—CYP2C19—Cholecalciferol—ulcerative colitis	0.016	0.0234	CbGbCtD
Apixaban—ABCG2—Dexamethasone—ulcerative colitis	0.0155	0.0227	CbGbCtD
Apixaban—CYP2C9—Nicotine—ulcerative colitis	0.0149	0.0217	CbGbCtD
Apixaban—ABCB1—Methylprednisolone—ulcerative colitis	0.0148	0.0216	CbGbCtD
Apixaban—CYP3A5—Hydrocortisone—ulcerative colitis	0.0138	0.0202	CbGbCtD
Apixaban—CYP2C9—Cholecalciferol—ulcerative colitis	0.0133	0.0195	CbGbCtD
Apixaban—CYP2C8—Hydrocortisone—ulcerative colitis	0.0133	0.0194	CbGbCtD
Apixaban—CYP2C19—Prednisone—ulcerative colitis	0.0111	0.0162	CbGbCtD
Apixaban—ABCB1—Betamethasone—ulcerative colitis	0.00962	0.0141	CbGbCtD
Apixaban—ABCB1—Prednisolone—ulcerative colitis	0.00949	0.0139	CbGbCtD
Apixaban—ABCB1—Hydrocortisone—ulcerative colitis	0.009	0.0132	CbGbCtD
Apixaban—ABCB1—Prednisone—ulcerative colitis	0.00896	0.0131	CbGbCtD
Apixaban—CYP3A4—Methylprednisolone—ulcerative colitis	0.00886	0.013	CbGbCtD
Apixaban—CYP3A4—Nicotine—ulcerative colitis	0.00864	0.0126	CbGbCtD
Apixaban—CYP3A5—Dexamethasone—ulcerative colitis	0.0086	0.0126	CbGbCtD
Apixaban—CYP2C8—Dexamethasone—ulcerative colitis	0.00826	0.0121	CbGbCtD
Apixaban—CYP3A4—Cholecalciferol—ulcerative colitis	0.00775	0.0113	CbGbCtD
Apixaban—CYP2C19—Dexamethasone—ulcerative colitis	0.00693	0.0101	CbGbCtD
Apixaban—CYP3A4—Triamcinolone—ulcerative colitis	0.00672	0.00982	CbGbCtD
Apixaban—CYP2C9—Dexamethasone—ulcerative colitis	0.00576	0.00843	CbGbCtD
Apixaban—CYP3A4—Betamethasone—ulcerative colitis	0.00576	0.00843	CbGbCtD
Apixaban—CYP3A4—Prednisolone—ulcerative colitis	0.00569	0.00831	CbGbCtD
Apixaban—ABCB1—Dexamethasone—ulcerative colitis	0.00559	0.00818	CbGbCtD
Apixaban—CYP3A4—Hydrocortisone—ulcerative colitis	0.00539	0.00788	CbGbCtD
Apixaban—CYP3A4—Prednisone—ulcerative colitis	0.00537	0.00785	CbGbCtD
Apixaban—F10—Common Pathway—PROCR—ulcerative colitis	0.00348	0.181	CbGpPWpGaD
Apixaban—CYP3A4—Dexamethasone—ulcerative colitis	0.00335	0.0049	CbGbCtD
Apixaban—F10—Formation of Fibrin Clot (Clotting Cascade)—PROCR—ulcerative colitis	0.002	0.104	CbGpPWpGaD
Apixaban—F10—Complement and Coagulation Cascades—MASP2—ulcerative colitis	0.000973	0.0506	CbGpPWpGaD
Apixaban—F10—Beta2 integrin cell surface interactions—ITGAL—ulcerative colitis	0.00091	0.0473	CbGpPWpGaD
Apixaban—ABCG2—Abacavir transmembrane transport—ABCB1—ulcerative colitis	0.000811	0.0421	CbGpPWpGaD
Apixaban—F10—Beta2 integrin cell surface interactions—FCGR2A—ulcerative colitis	0.000789	0.041	CbGpPWpGaD
Apixaban—Blood alkaline phosphatase increased—Budesonide—ulcerative colitis	0.000576	0.00871	CcSEcCtD
Apixaban—F10—Beta2 integrin cell surface interactions—VCAM1—ulcerative colitis	0.000553	0.0287	CbGpPWpGaD
Apixaban—Melaena—Mesalazine—ulcerative colitis	0.000549	0.00829	CcSEcCtD
Apixaban—Hepatobiliary disease—Mercaptopurine—ulcerative colitis	0.000547	0.00827	CcSEcCtD
Apixaban—Epistaxis—Nicotine—ulcerative colitis	0.000529	0.00799	CcSEcCtD
Apixaban—Ecchymosis—Mesalazine—ulcerative colitis	0.000508	0.00767	CcSEcCtD
Apixaban—Petechiae—Prednisolone—ulcerative colitis	0.000497	0.00751	CcSEcCtD
Apixaban—Petechiae—Hydrocortisone—ulcerative colitis	0.000485	0.00733	CcSEcCtD
Apixaban—Immune system disorder—Mercaptopurine—ulcerative colitis	0.000469	0.00709	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Mesalazine—ulcerative colitis	0.000469	0.00708	CcSEcCtD
Apixaban—ABCG2—Abacavir transport and metabolism—ABCB1—ulcerative colitis	0.000466	0.0242	CbGpPWpGaD
Apixaban—Contusion—Hydrocortisone—ulcerative colitis	0.000458	0.00692	CcSEcCtD
Apixaban—Petechiae—Triamcinolone—ulcerative colitis	0.000457	0.00691	CcSEcCtD
Apixaban—CYP2J2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000456	0.0237	CbGpPWpGaD
Apixaban—Petechiae—Methylprednisolone—ulcerative colitis	0.000456	0.00689	CcSEcCtD
Apixaban—Immune system disorder—Nicotine—ulcerative colitis	0.000455	0.00687	CcSEcCtD
Apixaban—Mediastinal disorder—Nicotine—ulcerative colitis	0.000454	0.00686	CcSEcCtD
Apixaban—Breast disorder—Budesonide—ulcerative colitis	0.000453	0.00684	CcSEcCtD
Apixaban—Rectal haemorrhage—Hydrocortisone—ulcerative colitis	0.000442	0.00668	CcSEcCtD
Apixaban—Anaemia—Mercaptopurine—ulcerative colitis	0.000418	0.00632	CcSEcCtD
Apixaban—Petechiae—Dexamethasone—ulcerative colitis	0.000415	0.00627	CcSEcCtD
Apixaban—Petechiae—Betamethasone—ulcerative colitis	0.000415	0.00627	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Mesalazine—ulcerative colitis	0.000408	0.00616	CcSEcCtD
Apixaban—Syncope—Nicotine—ulcerative colitis	0.000393	0.00594	CcSEcCtD
Apixaban—Contusion—Dexamethasone—ulcerative colitis	0.000391	0.00591	CcSEcCtD
Apixaban—Contusion—Betamethasone—ulcerative colitis	0.000391	0.00591	CcSEcCtD
Apixaban—Loss of consciousness—Nicotine—ulcerative colitis	0.000385	0.00582	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000382	0.00578	CcSEcCtD
Apixaban—F10—Beta2 integrin cell surface interactions—ICAM1—ulcerative colitis	0.000377	0.0196	CbGpPWpGaD
Apixaban—Liver function test abnormal—Mesalazine—ulcerative colitis	0.000376	0.00569	CcSEcCtD
Apixaban—Ecchymosis—Prednisolone—ulcerative colitis	0.00037	0.00559	CcSEcCtD
Apixaban—Breast disorder—Mesalazine—ulcerative colitis	0.000368	0.00557	CcSEcCtD
Apixaban—Haematuria—Budesonide—ulcerative colitis	0.000368	0.00557	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Mesalazine—ulcerative colitis	0.000367	0.00555	CcSEcCtD
Apixaban—F10—Post-translational protein modification—MUC3A—ulcerative colitis	0.000366	0.019	CbGpPWpGaD
Apixaban—Epistaxis—Budesonide—ulcerative colitis	0.000364	0.00551	CcSEcCtD
Apixaban—Thrombocytopenia—Mercaptopurine—ulcerative colitis	0.000361	0.00546	CcSEcCtD
Apixaban—Petechiae—Prednisone—ulcerative colitis	0.000361	0.00546	CcSEcCtD
Apixaban—Ecchymosis—Hydrocortisone—ulcerative colitis	0.000361	0.00546	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Mesalazine—ulcerative colitis	0.00036	0.00543	CcSEcCtD
Apixaban—Skin disorder—Mercaptopurine—ulcerative colitis	0.000359	0.00542	CcSEcCtD
Apixaban—Anaphylactic shock—Nicotine—ulcerative colitis	0.000358	0.00541	CcSEcCtD
Apixaban—Shock—Nicotine—ulcerative colitis	0.000352	0.00532	CcSEcCtD
Apixaban—Nervous system disorder—Nicotine—ulcerative colitis	0.000351	0.0053	CcSEcCtD
Apixaban—Haemoglobin—Budesonide—ulcerative colitis	0.000349	0.00527	CcSEcCtD
Apixaban—Haemorrhage—Budesonide—ulcerative colitis	0.000347	0.00524	CcSEcCtD
Apixaban—Urinary tract disorder—Budesonide—ulcerative colitis	0.000342	0.00517	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisolone—ulcerative colitis	0.000341	0.00516	CcSEcCtD
Apixaban—Connective tissue disorder—Budesonide—ulcerative colitis	0.000341	0.00515	CcSEcCtD
Apixaban—Contusion—Prednisone—ulcerative colitis	0.000341	0.00515	CcSEcCtD
Apixaban—Ecchymosis—Triamcinolone—ulcerative colitis	0.00034	0.00514	CcSEcCtD
Apixaban—Urethral disorder—Budesonide—ulcerative colitis	0.00034	0.00514	CcSEcCtD
Apixaban—Ecchymosis—Methylprednisolone—ulcerative colitis	0.000339	0.00513	CcSEcCtD
Apixaban—Hypotension—Nicotine—ulcerative colitis	0.000334	0.00505	CcSEcCtD
Apixaban—Diabetes mellitus—Hydrocortisone—ulcerative colitis	0.000333	0.00504	CcSEcCtD
Apixaban—Hepatobiliary disease—Azathioprine—ulcerative colitis	0.000326	0.00493	CcSEcCtD
Apixaban—Eye disorder—Budesonide—ulcerative colitis	0.000324	0.0049	CcSEcCtD
Apixaban—CYP2J2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.00032	0.0166	CbGpPWpGaD
Apixaban—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000319	0.00482	CcSEcCtD
Apixaban—Angiopathy—Budesonide—ulcerative colitis	0.000315	0.00475	CcSEcCtD
Apixaban—Diabetes mellitus—Triamcinolone—ulcerative colitis	0.000314	0.00474	CcSEcCtD
Apixaban—Immune system disorder—Budesonide—ulcerative colitis	0.000313	0.00473	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Methylprednisolone—ulcerative colitis	0.000313	0.00473	CcSEcCtD
Apixaban—Diabetes mellitus—Methylprednisolone—ulcerative colitis	0.000313	0.00473	CcSEcCtD
Apixaban—Mediastinal disorder—Budesonide—ulcerative colitis	0.000313	0.00472	CcSEcCtD
Apixaban—Haemoglobin—Azathioprine—ulcerative colitis	0.000311	0.0047	CcSEcCtD
Apixaban—Haemorrhage—Azathioprine—ulcerative colitis	0.00031	0.00468	CcSEcCtD
Apixaban—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000309	0.00467	CcSEcCtD
Apixaban—Ecchymosis—Dexamethasone—ulcerative colitis	0.000309	0.00466	CcSEcCtD
Apixaban—Ecchymosis—Betamethasone—ulcerative colitis	0.000309	0.00466	CcSEcCtD
Apixaban—Haematuria—Mesalazine—ulcerative colitis	0.0003	0.00453	CcSEcCtD
Apixaban—Hepatobiliary disease—Mesalazine—ulcerative colitis	0.000297	0.00449	CcSEcCtD
Apixaban—Epistaxis—Mesalazine—ulcerative colitis	0.000296	0.00448	CcSEcCtD
Apixaban—Diabetes mellitus—Betamethasone—ulcerative colitis	0.000285	0.0043	CcSEcCtD
Apixaban—Diabetes mellitus—Dexamethasone—ulcerative colitis	0.000285	0.0043	CcSEcCtD
Apixaban—Haemoglobin—Mesalazine—ulcerative colitis	0.000283	0.00428	CcSEcCtD
Apixaban—Haemorrhage—Mesalazine—ulcerative colitis	0.000282	0.00426	CcSEcCtD
Apixaban—Immune system disorder—Azathioprine—ulcerative colitis	0.00028	0.00423	CcSEcCtD
Apixaban—Mediastinal disorder—Azathioprine—ulcerative colitis	0.000279	0.00422	CcSEcCtD
Apixaban—Anaemia—Budesonide—ulcerative colitis	0.000279	0.00422	CcSEcCtD
Apixaban—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000279	0.00421	CcSEcCtD
Apixaban—Connective tissue disorder—Mesalazine—ulcerative colitis	0.000277	0.00419	CcSEcCtD
Apixaban—Urethral disorder—Mesalazine—ulcerative colitis	0.000276	0.00418	CcSEcCtD
Apixaban—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000272	0.00411	CcSEcCtD
Apixaban—Syncope—Budesonide—ulcerative colitis	0.000271	0.00409	CcSEcCtD
Apixaban—Ecchymosis—Prednisone—ulcerative colitis	0.000269	0.00406	CcSEcCtD
Apixaban—Loss of consciousness—Budesonide—ulcerative colitis	0.000265	0.00401	CcSEcCtD
Apixaban—Hypersensitivity—Nicotine—ulcerative colitis	0.000264	0.00398	CcSEcCtD
Apixaban—Eye disorder—Mesalazine—ulcerative colitis	0.000264	0.00398	CcSEcCtD
Apixaban—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000256	0.0133	CbGpPWpGaD
Apixaban—Angiopathy—Mesalazine—ulcerative colitis	0.000256	0.00387	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000256	0.00386	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000255	0.00386	CcSEcCtD
Apixaban—Immune system disorder—Mesalazine—ulcerative colitis	0.000255	0.00385	CcSEcCtD
Apixaban—Mediastinal disorder—Mesalazine—ulcerative colitis	0.000254	0.00384	CcSEcCtD
Apixaban—Anaemia—Azathioprine—ulcerative colitis	0.000249	0.00376	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisone—ulcerative colitis	0.000248	0.00375	CcSEcCtD
Apixaban—Anaphylactic shock—Budesonide—ulcerative colitis	0.000246	0.00372	CcSEcCtD
Apixaban—Breast disorder—Methylprednisolone—ulcerative colitis	0.000246	0.00372	CcSEcCtD
Apixaban—Shock—Budesonide—ulcerative colitis	0.000242	0.00366	CcSEcCtD
Apixaban—Nervous system disorder—Budesonide—ulcerative colitis	0.000242	0.00365	CcSEcCtD
Apixaban—F10—Hemostasis—PROCR—ulcerative colitis	0.000241	0.0125	CbGpPWpGaD
Apixaban—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.00024	0.00363	CcSEcCtD
Apixaban—Skin disorder—Budesonide—ulcerative colitis	0.000239	0.00362	CcSEcCtD
Apixaban—Dizziness—Nicotine—ulcerative colitis	0.000237	0.00357	CcSEcCtD
Apixaban—Rash—Mercaptopurine—ulcerative colitis	0.000233	0.00352	CcSEcCtD
Apixaban—Dermatitis—Mercaptopurine—ulcerative colitis	0.000233	0.00351	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000228	0.00344	CcSEcCtD
Apixaban—Anaemia—Mesalazine—ulcerative colitis	0.000227	0.00343	CcSEcCtD
Apixaban—Rash—Nicotine—ulcerative colitis	0.000226	0.00341	CcSEcCtD
Apixaban—Dermatitis—Nicotine—ulcerative colitis	0.000225	0.0034	CcSEcCtD
Apixaban—Syncope—Mesalazine—ulcerative colitis	0.00022	0.00333	CcSEcCtD
Apixaban—Nausea—Mercaptopurine—ulcerative colitis	0.000219	0.00331	CcSEcCtD
Apixaban—Loss of consciousness—Mesalazine—ulcerative colitis	0.000216	0.00326	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Prednisone—ulcerative colitis	0.000216	0.00326	CcSEcCtD
Apixaban—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000215	0.00325	CcSEcCtD
Apixaban—Skin disorder—Azathioprine—ulcerative colitis	0.000214	0.00323	CcSEcCtD
Apixaban—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000213	0.00321	CcSEcCtD
Apixaban—Nausea—Nicotine—ulcerative colitis	0.000213	0.00321	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000208	0.00314	CcSEcCtD
Apixaban—Haemoglobin—Prednisolone—ulcerative colitis	0.000206	0.00312	CcSEcCtD
Apixaban—Hypotension—Azathioprine—ulcerative colitis	0.000206	0.00311	CcSEcCtD
Apixaban—Haemorrhage—Prednisolone—ulcerative colitis	0.000205	0.0031	CcSEcCtD
Apixaban—Haemoglobin—Hydrocortisone—ulcerative colitis	0.000202	0.00305	CcSEcCtD
Apixaban—Haemorrhage—Hydrocortisone—ulcerative colitis	0.000201	0.00303	CcSEcCtD
Apixaban—Anaphylactic shock—Mesalazine—ulcerative colitis	0.0002	0.00303	CcSEcCtD
Apixaban—Epistaxis—Triamcinolone—ulcerative colitis	0.000198	0.003	CcSEcCtD
Apixaban—Shock—Mesalazine—ulcerative colitis	0.000197	0.00298	CcSEcCtD
Apixaban—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000197	0.00298	CcSEcCtD
Apixaban—Nervous system disorder—Mesalazine—ulcerative colitis	0.000197	0.00297	CcSEcCtD
Apixaban—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000196	0.00296	CcSEcCtD
Apixaban—Skin disorder—Mesalazine—ulcerative colitis	0.000195	0.00294	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.00019	0.00287	CcSEcCtD
Apixaban—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00019	0.00287	CcSEcCtD
Apixaban—Haemoglobin—Triamcinolone—ulcerative colitis	0.00019	0.00287	CcSEcCtD
Apixaban—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000189	0.00286	CcSEcCtD
Apixaban—Haemorrhage—Triamcinolone—ulcerative colitis	0.000189	0.00285	CcSEcCtD
Apixaban—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000188	0.00285	CcSEcCtD
Apixaban—Eye disorder—Hydrocortisone—ulcerative colitis	0.000187	0.00283	CcSEcCtD
Apixaban—Hypotension—Mesalazine—ulcerative colitis	0.000187	0.00283	CcSEcCtD
Apixaban—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000186	0.00964	CbGpPWpGaD
Apixaban—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000185	0.0028	CcSEcCtD
Apixaban—Hypersensitivity—Budesonide—ulcerative colitis	0.000182	0.00274	CcSEcCtD
Apixaban—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000181	0.00274	CcSEcCtD
Apixaban—F10—Post-translational protein modification—MUC2—ulcerative colitis	0.000179	0.00928	CbGpPWpGaD
Apixaban—Eye disorder—Methylprednisolone—ulcerative colitis	0.000176	0.00266	CcSEcCtD
Apixaban—CYP2J2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000175	0.00909	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—MUC3A—ulcerative colitis	0.000174	0.00902	CbGpPWpGaD
Apixaban—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000173	0.00261	CcSEcCtD
Apixaban—Haemoglobin—Betamethasone—ulcerative colitis	0.000172	0.0026	CcSEcCtD
Apixaban—Haemoglobin—Dexamethasone—ulcerative colitis	0.000172	0.0026	CcSEcCtD
Apixaban—Haemorrhage—Betamethasone—ulcerative colitis	0.000171	0.00259	CcSEcCtD
Apixaban—Haemorrhage—Dexamethasone—ulcerative colitis	0.000171	0.00259	CcSEcCtD
Apixaban—Angiopathy—Methylprednisolone—ulcerative colitis	0.000171	0.00258	CcSEcCtD
Apixaban—Immune system disorder—Methylprednisolone—ulcerative colitis	0.00017	0.00257	CcSEcCtD
Apixaban—CYP2J2—Biological oxidations—PTGS1—ulcerative colitis	0.00017	0.00882	CbGpPWpGaD
Apixaban—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.00017	0.00257	CcSEcCtD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000165	0.00857	CbGpPWpGaD
Apixaban—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000164	0.00854	CbGpPWpGaD
Apixaban—Dizziness—Budesonide—ulcerative colitis	0.000163	0.00246	CcSEcCtD
Apixaban—Hypersensitivity—Azathioprine—ulcerative colitis	0.000162	0.00245	CcSEcCtD
Apixaban—Syncope—Prednisolone—ulcerative colitis	0.00016	0.00242	CcSEcCtD
Apixaban—Eye disorder—Dexamethasone—ulcerative colitis	0.00016	0.00242	CcSEcCtD
Apixaban—Eye disorder—Betamethasone—ulcerative colitis	0.00016	0.00242	CcSEcCtD
Apixaban—Loss of consciousness—Prednisolone—ulcerative colitis	0.000157	0.00237	CcSEcCtD
Apixaban—Syncope—Hydrocortisone—ulcerative colitis	0.000157	0.00237	CcSEcCtD
Apixaban—Angiopathy—Betamethasone—ulcerative colitis	0.000155	0.00235	CcSEcCtD
Apixaban—Angiopathy—Dexamethasone—ulcerative colitis	0.000155	0.00235	CcSEcCtD
Apixaban—Rash—Budesonide—ulcerative colitis	0.000155	0.00235	CcSEcCtD
Apixaban—Dermatitis—Budesonide—ulcerative colitis	0.000155	0.00235	CcSEcCtD
Apixaban—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000153	0.00232	CcSEcCtD
Apixaban—Haemoglobin—Prednisone—ulcerative colitis	0.00015	0.00227	CcSEcCtD
Apixaban—Haemorrhage—Prednisone—ulcerative colitis	0.000149	0.00225	CcSEcCtD
Apixaban—Hypersensitivity—Mesalazine—ulcerative colitis	0.000148	0.00223	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000148	0.00223	CcSEcCtD
Apixaban—Syncope—Triamcinolone—ulcerative colitis	0.000147	0.00223	CcSEcCtD
Apixaban—Syncope—Methylprednisolone—ulcerative colitis	0.000147	0.00222	CcSEcCtD
Apixaban—Connective tissue disorder—Prednisone—ulcerative colitis	0.000147	0.00222	CcSEcCtD
Apixaban—Nausea—Budesonide—ulcerative colitis	0.000146	0.00221	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000146	0.0022	CcSEcCtD
Apixaban—Dizziness—Azathioprine—ulcerative colitis	0.000145	0.0022	CcSEcCtD
Apixaban—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000144	0.00218	CcSEcCtD
Apixaban—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000144	0.00218	CcSEcCtD
Apixaban—Shock—Prednisolone—ulcerative colitis	0.000144	0.00217	CcSEcCtD
Apixaban—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000142	0.00215	CcSEcCtD
Apixaban—Shock—Hydrocortisone—ulcerative colitis	0.00014	0.00212	CcSEcCtD
Apixaban—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00014	0.00211	CcSEcCtD
Apixaban—Eye disorder—Prednisone—ulcerative colitis	0.000139	0.00211	CcSEcCtD
Apixaban—Rash—Azathioprine—ulcerative colitis	0.000139	0.0021	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000139	0.0021	CcSEcCtD
Apixaban—Dermatitis—Azathioprine—ulcerative colitis	0.000139	0.00209	CcSEcCtD
Apixaban—Skin disorder—Hydrocortisone—ulcerative colitis	0.000138	0.00209	CcSEcCtD
Apixaban—Angiopathy—Prednisone—ulcerative colitis	0.000135	0.00205	CcSEcCtD
Apixaban—Immune system disorder—Prednisone—ulcerative colitis	0.000135	0.00204	CcSEcCtD
Apixaban—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000134	0.00203	CcSEcCtD
Apixaban—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000134	0.00202	CcSEcCtD
Apixaban—Syncope—Dexamethasone—ulcerative colitis	0.000134	0.00202	CcSEcCtD
Apixaban—Syncope—Betamethasone—ulcerative colitis	0.000134	0.00202	CcSEcCtD
Apixaban—Hypotension—Hydrocortisone—ulcerative colitis	0.000133	0.00201	CcSEcCtD
Apixaban—Dizziness—Mesalazine—ulcerative colitis	0.000133	0.002	CcSEcCtD
Apixaban—Shock—Triamcinolone—ulcerative colitis	0.000132	0.00199	CcSEcCtD
Apixaban—Shock—Methylprednisolone—ulcerative colitis	0.000132	0.00199	CcSEcCtD
Apixaban—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000132	0.00684	CbGpPWpGaD
Apixaban—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000131	0.00198	CcSEcCtD
Apixaban—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000131	0.00198	CcSEcCtD
Apixaban—Loss of consciousness—Betamethasone—ulcerative colitis	0.000131	0.00198	CcSEcCtD
Apixaban—Nausea—Azathioprine—ulcerative colitis	0.000131	0.00197	CcSEcCtD
Apixaban—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—ulcerative colitis	0.000131	0.00679	CbGpPWpGaD
Apixaban—Skin disorder—Methylprednisolone—ulcerative colitis	0.00013	0.00196	CcSEcCtD
Apixaban—Rash—Mesalazine—ulcerative colitis	0.000126	0.00191	CcSEcCtD
Apixaban—Dermatitis—Mesalazine—ulcerative colitis	0.000126	0.00191	CcSEcCtD
Apixaban—Hypotension—Methylprednisolone—ulcerative colitis	0.000125	0.00189	CcSEcCtD
Apixaban—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000123	0.00186	CcSEcCtD
Apixaban—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000122	0.00184	CcSEcCtD
Apixaban—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000122	0.00184	CcSEcCtD
Apixaban—Anaemia—Prednisone—ulcerative colitis	0.00012	0.00181	CcSEcCtD
Apixaban—Shock—Dexamethasone—ulcerative colitis	0.00012	0.00181	CcSEcCtD
Apixaban—Shock—Betamethasone—ulcerative colitis	0.00012	0.00181	CcSEcCtD
Apixaban—Nervous system disorder—Betamethasone—ulcerative colitis	0.000119	0.0018	CcSEcCtD
Apixaban—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000119	0.0018	CcSEcCtD
Apixaban—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000119	0.0018	CcSEcCtD
Apixaban—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000119	0.0018	CcSEcCtD
Apixaban—Nausea—Mesalazine—ulcerative colitis	0.000119	0.0018	CcSEcCtD
Apixaban—Syncope—Prednisone—ulcerative colitis	0.000116	0.00176	CcSEcCtD
Apixaban—Loss of consciousness—Prednisone—ulcerative colitis	0.000114	0.00173	CcSEcCtD
Apixaban—CYP2C8—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000114	0.00592	CbGpPWpGaD
Apixaban—Hypotension—Betamethasone—ulcerative colitis	0.000114	0.00172	CcSEcCtD
Apixaban—Hypotension—Dexamethasone—ulcerative colitis	0.000114	0.00172	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00011	0.00166	CcSEcCtD
Apixaban—Hypersensitivity—Prednisolone—ulcerative colitis	0.000107	0.00162	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisone—ulcerative colitis	0.000106	0.0016	CcSEcCtD
Apixaban—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000105	0.00159	CcSEcCtD
Apixaban—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000105	0.00159	CcSEcCtD
Apixaban—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000105	0.00159	CcSEcCtD
Apixaban—Shock—Prednisone—ulcerative colitis	0.000104	0.00158	CcSEcCtD
Apixaban—Nervous system disorder—Prednisone—ulcerative colitis	0.000104	0.00157	CcSEcCtD
Apixaban—Skin disorder—Prednisone—ulcerative colitis	0.000103	0.00156	CcSEcCtD
Apixaban—ABCG2—HIF-1-alpha transcription factor network—ABCB1—ulcerative colitis	0.000103	0.00535	CbGpPWpGaD
Apixaban—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000102	0.00529	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000102	0.00528	CbGpPWpGaD
Apixaban—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000102	0.00527	CbGpPWpGaD
Apixaban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000101	0.00526	CbGpPWpGaD
Apixaban—Hypersensitivity—Triamcinolone—ulcerative colitis	9.88e-05	0.00149	CcSEcCtD
Apixaban—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.86e-05	0.00149	CcSEcCtD
Apixaban—Dizziness—Prednisolone—ulcerative colitis	9.65e-05	0.00146	CcSEcCtD
Apixaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	9.44e-05	0.00491	CbGpPWpGaD
Apixaban—Dizziness—Hydrocortisone—ulcerative colitis	9.42e-05	0.00142	CcSEcCtD
Apixaban—F10—Hemostasis—GNA12—ulcerative colitis	9.42e-05	0.00489	CbGpPWpGaD
Apixaban—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	9.28e-05	0.00482	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	9.27e-05	0.00482	CbGpPWpGaD
Apixaban—F10—Hemostasis—ITGAL—ulcerative colitis	9.24e-05	0.0048	CbGpPWpGaD
Apixaban—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	9.22e-05	0.00479	CbGpPWpGaD
Apixaban—Rash—Prednisolone—ulcerative colitis	9.2e-05	0.00139	CcSEcCtD
Apixaban—Dermatitis—Prednisolone—ulcerative colitis	9.19e-05	0.00139	CcSEcCtD
Apixaban—Rash—Hydrocortisone—ulcerative colitis	8.98e-05	0.00136	CcSEcCtD
Apixaban—Dermatitis—Hydrocortisone—ulcerative colitis	8.98e-05	0.00136	CcSEcCtD
Apixaban—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	8.92e-05	0.00463	CbGpPWpGaD
Apixaban—Dizziness—Triamcinolone—ulcerative colitis	8.87e-05	0.00134	CcSEcCtD
Apixaban—Dizziness—Methylprednisolone—ulcerative colitis	8.85e-05	0.00134	CcSEcCtD
Apixaban—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	8.84e-05	0.00459	CbGpPWpGaD
Apixaban—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	8.82e-05	0.00458	CbGpPWpGaD
Apixaban—Nausea—Prednisolone—ulcerative colitis	8.67e-05	0.00131	CcSEcCtD
Apixaban—F10—Metabolism of proteins—MUC2—ulcerative colitis	8.48e-05	0.0044	CbGpPWpGaD
Apixaban—Nausea—Hydrocortisone—ulcerative colitis	8.46e-05	0.00128	CcSEcCtD
Apixaban—Rash—Triamcinolone—ulcerative colitis	8.46e-05	0.00128	CcSEcCtD
Apixaban—Dermatitis—Triamcinolone—ulcerative colitis	8.45e-05	0.00128	CcSEcCtD
Apixaban—Rash—Methylprednisolone—ulcerative colitis	8.44e-05	0.00128	CcSEcCtD
Apixaban—Dermatitis—Methylprednisolone—ulcerative colitis	8.43e-05	0.00127	CcSEcCtD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	8.27e-05	0.0043	CbGpPWpGaD
Apixaban—Dizziness—Betamethasone—ulcerative colitis	8.05e-05	0.00122	CcSEcCtD
Apixaban—Dizziness—Dexamethasone—ulcerative colitis	8.05e-05	0.00122	CcSEcCtD
Apixaban—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.98e-05	0.00415	CbGpPWpGaD
Apixaban—Nausea—Triamcinolone—ulcerative colitis	7.97e-05	0.0012	CcSEcCtD
Apixaban—Nausea—Methylprednisolone—ulcerative colitis	7.95e-05	0.0012	CcSEcCtD
Apixaban—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	7.92e-05	0.00412	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	7.87e-05	0.00409	CbGpPWpGaD
Apixaban—Hypersensitivity—Prednisone—ulcerative colitis	7.81e-05	0.00118	CcSEcCtD
Apixaban—Rash—Betamethasone—ulcerative colitis	7.68e-05	0.00116	CcSEcCtD
Apixaban—Rash—Dexamethasone—ulcerative colitis	7.68e-05	0.00116	CcSEcCtD
Apixaban—Dermatitis—Dexamethasone—ulcerative colitis	7.67e-05	0.00116	CcSEcCtD
Apixaban—Dermatitis—Betamethasone—ulcerative colitis	7.67e-05	0.00116	CcSEcCtD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.55e-05	0.00392	CbGpPWpGaD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.54e-05	0.00392	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	7.26e-05	0.00377	CbGpPWpGaD
Apixaban—Nausea—Dexamethasone—ulcerative colitis	7.23e-05	0.00109	CcSEcCtD
Apixaban—Nausea—Betamethasone—ulcerative colitis	7.23e-05	0.00109	CcSEcCtD
Apixaban—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.13e-05	0.0037	CbGpPWpGaD
Apixaban—Dizziness—Prednisone—ulcerative colitis	7.01e-05	0.00106	CcSEcCtD
Apixaban—CYP2J2—Metabolism—CHP1—ulcerative colitis	6.96e-05	0.00362	CbGpPWpGaD
Apixaban—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	6.96e-05	0.00361	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	6.88e-05	0.00358	CbGpPWpGaD
Apixaban—Rash—Prednisone—ulcerative colitis	6.68e-05	0.00101	CcSEcCtD
Apixaban—Dermatitis—Prednisone—ulcerative colitis	6.68e-05	0.00101	CcSEcCtD
Apixaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.58e-05	0.00342	CbGpPWpGaD
Apixaban—F10—Hemostasis—CALM3—ulcerative colitis	6.55e-05	0.0034	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.52e-05	0.00339	CbGpPWpGaD
Apixaban—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.5e-05	0.00338	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	6.4e-05	0.00332	CbGpPWpGaD
Apixaban—Nausea—Prednisone—ulcerative colitis	6.3e-05	0.000951	CcSEcCtD
Apixaban—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.15e-05	0.0032	CbGpPWpGaD
Apixaban—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	6.12e-05	0.00318	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	6.02e-05	0.00313	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—DLD—ulcerative colitis	6.01e-05	0.00312	CbGpPWpGaD
Apixaban—ABCG2—Fluoropyrimidine Activity—TP53—ulcerative colitis	5.84e-05	0.00303	CbGpPWpGaD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	5.83e-05	0.00303	CbGpPWpGaD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	5.82e-05	0.00302	CbGpPWpGaD
Apixaban—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.55e-05	0.00288	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—GHRL—ulcerative colitis	5.32e-05	0.00277	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	5.3e-05	0.00275	CbGpPWpGaD
Apixaban—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.26e-05	0.00273	CbGpPWpGaD
Apixaban—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.23e-05	0.00272	CbGpPWpGaD
Apixaban—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	4.9e-05	0.00254	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.87e-05	0.00253	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.87e-05	0.00253	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL10—ulcerative colitis	4.68e-05	0.00243	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	4.47e-05	0.00232	CbGpPWpGaD
Apixaban—CYP2C8—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.37e-05	0.00227	CbGpPWpGaD
Apixaban—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.28e-05	0.00223	CbGpPWpGaD
Apixaban—CYP2C8—Biological oxidations—PTGS1—ulcerative colitis	4.24e-05	0.0022	CbGpPWpGaD
Apixaban—F10—Hemostasis—MMP1—ulcerative colitis	4.21e-05	0.00219	CbGpPWpGaD
Apixaban—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	4.07e-05	0.00212	CbGpPWpGaD
Apixaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	4.06e-05	0.00211	CbGpPWpGaD
Apixaban—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.9e-05	0.00202	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	3.81e-05	0.00198	CbGpPWpGaD
Apixaban—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	3.78e-05	0.00197	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	3.77e-05	0.00196	CbGpPWpGaD
Apixaban—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.55e-05	0.00185	CbGpPWpGaD
Apixaban—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	3.45e-05	0.00179	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	3.39e-05	0.00176	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	3.34e-05	0.00174	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—MMP1—ulcerative colitis	3.31e-05	0.00172	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	3.25e-05	0.00169	CbGpPWpGaD
Apixaban—F10—Hemostasis—ALB—ulcerative colitis	3.19e-05	0.00166	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.18e-05	0.00165	CbGpPWpGaD
Apixaban—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.04e-05	0.00158	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.04e-05	0.00158	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	3.02e-05	0.00157	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	3.01e-05	0.00156	CbGpPWpGaD
Apixaban—F10—Hemostasis—JAK2—ulcerative colitis	2.96e-05	0.00154	CbGpPWpGaD
Apixaban—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	2.95e-05	0.00153	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS1—ulcerative colitis	2.9e-05	0.00151	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.86e-05	0.00148	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.82e-05	0.00146	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CHP1—ulcerative colitis	2.8e-05	0.00145	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	2.75e-05	0.00143	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	2.63e-05	0.00137	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	2.63e-05	0.00137	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—CALM3—ulcerative colitis	2.62e-05	0.00136	CbGpPWpGaD
Apixaban—F10—Hemostasis—IL2—ulcerative colitis	2.59e-05	0.00134	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	2.56e-05	0.00133	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.5e-05	0.0013	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	2.45e-05	0.00128	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—IL2—ulcerative colitis	2.45e-05	0.00127	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—DLD—ulcerative colitis	2.42e-05	0.00126	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.35e-05	0.00122	CbGpPWpGaD
Apixaban—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.28e-05	0.00118	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.19e-05	0.00114	CbGpPWpGaD
Apixaban—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.19e-05	0.00114	CbGpPWpGaD
Apixaban—F10—Metabolism of proteins—CXCL8—ulcerative colitis	2.13e-05	0.00111	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ABCB1—ulcerative colitis	2.03e-05	0.00106	CbGpPWpGaD
Apixaban—F10—Hemostasis—TGFB1—ulcerative colitis	2.02e-05	0.00105	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CHP1—ulcerative colitis	2.01e-05	0.00104	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	1.91e-05	0.000991	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ADCY5—ulcerative colitis	1.9e-05	0.000986	CbGpPWpGaD
Apixaban—ABCB1—Allograft Rejection—TNF—ulcerative colitis	1.78e-05	0.000925	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.75e-05	0.000908	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CHP1—ulcerative colitis	1.74e-05	0.000903	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—DLD—ulcerative colitis	1.73e-05	0.0009	CbGpPWpGaD
Apixaban—F10—Hemostasis—TP53—ulcerative colitis	1.66e-05	0.000862	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.64e-05	0.000853	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.63e-05	0.000847	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.63e-05	0.000846	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.55e-05	0.000806	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CHP1—ulcerative colitis	1.51e-05	0.000787	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—DLD—ulcerative colitis	1.5e-05	0.000779	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.45e-05	0.000755	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PPARG—ulcerative colitis	1.42e-05	0.000735	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.41e-05	0.000735	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—DLD—ulcerative colitis	1.34e-05	0.000696	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.33e-05	0.000689	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—DLD—ulcerative colitis	1.31e-05	0.000679	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.3e-05	0.000676	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—ALB—ulcerative colitis	1.27e-05	0.000661	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—DLD—ulcerative colitis	1.22e-05	0.000634	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.21e-05	0.000628	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.17e-05	0.000607	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.13e-05	0.000588	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.13e-05	0.000587	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PTGS2—ulcerative colitis	1.11e-05	0.000578	CbGpPWpGaD
Apixaban—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.09e-05	0.000568	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CALM3—ulcerative colitis	1.05e-05	0.000547	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—DLD—ulcerative colitis	1.04e-05	0.000542	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	9.41e-06	0.000489	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.33e-06	0.000485	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.81e-06	0.000458	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	8.79e-06	0.000457	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS1—ulcerative colitis	8.37e-06	0.000435	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ABCB1—ulcerative colitis	8.18e-06	0.000425	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—DLD—ulcerative colitis	8.05e-06	0.000418	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.93e-06	0.000412	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.75e-06	0.000403	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ADCY5—ulcerative colitis	7.63e-06	0.000397	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CALM3—ulcerative colitis	7.54e-06	0.000392	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS1—ulcerative colitis	7.25e-06	0.000377	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.13e-06	0.000371	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.08e-06	0.000368	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.53e-06	0.000339	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS1—ulcerative colitis	6.47e-06	0.000336	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.46e-06	0.000335	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.37e-06	0.000331	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS1—ulcerative colitis	6.32e-06	0.000328	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.24e-06	0.000324	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.91e-06	0.000307	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS1—ulcerative colitis	5.9e-06	0.000307	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCB1—ulcerative colitis	5.86e-06	0.000305	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CALM3—ulcerative colitis	5.83e-06	0.000303	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.81e-06	0.000302	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PPARG—ulcerative colitis	5.69e-06	0.000296	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CALM3—ulcerative colitis	5.69e-06	0.000296	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.57e-06	0.000289	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.52e-06	0.000287	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ADCY5—ulcerative colitis	5.47e-06	0.000284	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.31e-06	0.000276	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—ulcerative colitis	5.12e-06	0.000266	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.08e-06	0.000264	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—ulcerative colitis	5.08e-06	0.000264	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS1—ulcerative colitis	5.04e-06	0.000262	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.96e-06	0.000258	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.74e-06	0.000246	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.54e-06	0.000236	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—ulcerative colitis	4.53e-06	0.000235	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTGS2—ulcerative colitis	4.48e-06	0.000233	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.34e-06	0.000225	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.23e-06	0.00022	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.13e-06	0.000215	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.13e-06	0.000214	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PPARG—ulcerative colitis	4.08e-06	0.000212	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.89e-06	0.000202	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.86e-06	0.0002	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—ulcerative colitis	3.67e-06	0.000191	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.53e-06	0.000184	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.53e-06	0.000183	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.5e-06	0.000182	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.29e-06	0.000171	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTGS2—ulcerative colitis	3.21e-06	0.000167	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—ulcerative colitis	3.18e-06	0.000165	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.15e-06	0.000164	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PPARG—ulcerative colitis	3.08e-06	0.00016	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.88e-06	0.000149	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—ulcerative colitis	2.84e-06	0.000147	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.78e-06	0.000144	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—ulcerative colitis	2.77e-06	0.000144	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.73e-06	0.000142	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—ulcerative colitis	2.59e-06	0.000134	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.54e-06	0.000132	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.48e-06	0.000129	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.46e-06	0.000128	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.42e-06	0.000126	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.26e-06	0.000118	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—ulcerative colitis	2.21e-06	0.000115	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.93e-06	0.0001	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.9e-06	9.85e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—ulcerative colitis	1.7e-06	8.86e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.49e-06	7.75e-05	CbGpPWpGaD
